Arcadia Biosciences Inc
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief,… Read more
Arcadia Biosciences Inc (RKDA) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.047x
Based on the latest financial reports, Arcadia Biosciences Inc (RKDA) has a cash flow conversion efficiency ratio of -0.047x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-257.00K) by net assets ($5.44 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Arcadia Biosciences Inc - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Arcadia Biosciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Arcadia Biosciences Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Arcadia Biosciences Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ARHT Media Inc
OTCQB:ARHTF
|
0.118x |
|
HIKARI TSUSHIN
MU:HIK
|
0.044x |
|
Wästbygg Gruppen AB (publ)
ST:WBGR-B
|
0.046x |
|
Duta Anggada Realty Tbk
JK:DART
|
-0.001x |
|
AKS Corporation Public Company Limited
BK:AKS
|
-0.360x |
|
XP Chemistries AB
ST:XPC
|
-0.113x |
|
Nl Development Public Company Limited
BK:NL
|
0.146x |
|
NEVADA SUNRISE METALS
F:K4L
|
N/A |
Annual Cash Flow Conversion Efficiency for Arcadia Biosciences Inc (2012–2024)
The table below shows the annual cash flow conversion efficiency of Arcadia Biosciences Inc from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $6.22 Million | $-9.63 Million | -1.547x | -28.49% |
| 2023-12-31 | $12.70 Million | $-15.29 Million | -1.204x | -80.03% |
| 2022-12-31 | $20.90 Million | $-13.98 Million | -0.669x | +19.35% |
| 2021-12-31 | $31.20 Million | $-25.87 Million | -0.829x | +21.65% |
| 2020-12-31 | $28.55 Million | $-30.22 Million | -1.058x | +48.76% |
| 2019-12-31 | $8.33 Million | $-17.20 Million | -2.066x | -94.19% |
| 2018-12-31 | $12.81 Million | $-13.63 Million | -1.064x | +39.01% |
| 2017-12-31 | $8.01 Million | $-13.96 Million | -1.744x | -127.00% |
| 2016-12-31 | $22.20 Million | $-17.05 Million | -0.768x | -104.55% |
| 2015-12-31 | $40.23 Million | $-15.11 Million | -0.376x | -104.79% |
| 2014-12-31 | $-1.89 Million | $-14.79 Million | 7.845x | +1292.38% |
| 2013-12-31 | $-17.30 Million | $-9.74 Million | 0.563x | -66.60% |
| 2012-12-31 | $-5.68 Million | $-9.59 Million | 1.687x | -- |